Boston Scientific has implanted the first chinese patient with its Teligen implantable cardioverter defibrillator (ICD).
The Teligen family of ICDs available in China are smallest and thinnest high-energy devices and are mainly designed to treat sudden cardiac death.
Chinese Society of Pacing and Electrophysiology chairman Shu Zhang said the Teligen devices provide patients the thinnest ICDs with the longest projected longevity available, without compromising therapy options.
Boston Scientific Cardiac Rhythm Management group senior vice president and president Joe Fitzgerald said they believe today’s first implant of their advanced ICDs combined with their recent launch of the Promus Element Plus Coronary Stent System in China positions them for future growth in this important market.
The company said the State Food and Drug Administration (SFDA) of the People’s Republic of China has certified its Teligen family of devices in November 2011.